Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

New Developments in Pichia pastoris Expression System, Review and Update.

Baghban R, Farajnia S, Ghasemi Y, Mortazavi M, Zarghami N, Samadi N.

Curr Pharm Biotechnol. 2018 Jul 17. doi: 10.2174/1389201019666180718093037. [Epub ahead of print]

PMID:
30019641
2.

Novel angiotensin receptor blocker, azilsartan induces oxidative stress and NFkB-mediated apoptosis in hepatocellular carcinoma cell line HepG2.

Ahmadian E, Khosroushahi AY, Eftekhari A, Farajnia S, Babaei H, Eghbal MA.

Biomed Pharmacother. 2018 Mar;99:939-946. doi: 10.1016/j.biopha.2018.01.117. Epub 2018 Feb 20.

PMID:
29710494
3.

CRISPR and personalized Treg therapy: new insights into the treatment of rheumatoid arthritis.

Safari F, Farajnia S, Arya M, Zarredar H, Nasrolahi A.

Immunopharmacol Immunotoxicol. 2018 Jun;40(3):201-211. doi: 10.1080/08923973.2018.1437625. Epub 2018 Feb 23.

PMID:
29473438
4.

New Developments in CRISPR Technology: Improvements in Specificity and Efficiency.

Safari F, Farajnia S, Ghasemi Y, Zarghami N.

Curr Pharm Biotechnol. 2017;18(13):1038-1054. doi: 10.2174/1389201019666180209120533. Review.

PMID:
29424307
5.

Potential Molecular Targets in the Treatment of Lung Cancer Using siRNA Technology.

Zarredar H, Ansarin K, Baradaran B, Ahdi Khosroshahi S, Farajnia S.

Cancer Invest. 2018 Jan 2;36(1):37-58. doi: 10.1080/07357907.2017.1416393. Epub 2018 Jan 16. Review.

PMID:
29336624
6.

Antibody based EpCAM targeted Therapy of Cancer, Review and update.

Eyvazi S, Farajnia S, Dastmalchi S, Kanipour F, Zarredar H, Bandehpour M.

Curr Cancer Drug Targets. 2018 Jan 1. doi: 10.2174/1568009618666180102102311. [Epub ahead of print]

PMID:
29295696
7.

RGD delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice.

Jahanban-Esfahlan R, Seidi K, Monhemi H, Adli ADF, Minofar B, Zare P, Farajzadeh D, Farajnia S, Behzadi R, Abbasi MM, Zarghami N, Javaheri T.

Sci Rep. 2017 Aug 15;7(1):8126. doi: 10.1038/s41598-017-05326-9.

8.

The Effect of Dried Glycyrrhiza Glabra L. Extract on Obesity Management with Regard to PPAR-γ2 (Pro12Ala) Gene Polymorphism in Obese Subjects Following an Energy Restricted Diet.

Namazi N, Alizadeh M, Mirtaheri E, Farajnia S.

Adv Pharm Bull. 2017 Jun;7(2):221-228. doi: 10.15171/apb.2017.027. Epub 2017 Jun 30.

9.

Erratum to: Increased glutamic acid decarboxylase expression in the hypothalamic suprachiasmatic nucleus in depression.

Wu X, Balesar R, Lu J, Farajnia S, Zhu Q, Huang M, Bao AM, Swaab DF.

Brain Struct Funct. 2017 Nov;222(8):3863. doi: 10.1007/s00429-017-1465-4. No abstract available.

PMID:
28699027
10.

Apoptosis and Caspase 3 Pathway Role on Anti-Proliferative Effects of Scrophulariaoxy Sepala Methanolic Extract on Caco-2 Cells.

Namvaran A, Fazeli M, Farajnia S, Hamidian G, Rezazadeh H.

Drug Res (Stuttg). 2017 Sep;67(9):547-552. doi: 10.1055/s-0043-110483. Epub 2017 Jun 19.

PMID:
28628925
11.

Increased glutamic acid decarboxylase expression in the hypothalamic suprachiasmatic nucleus in depression.

Wu X, Balesar R, Lu J, Farajnia S, Zhu Q, Huang M, Bao AM, Swaab DF.

Brain Struct Funct. 2017 Dec;222(9):4079-4088. doi: 10.1007/s00429-017-1442-y. Epub 2017 Jun 12. Erratum in: Brain Struct Funct. 2017 Nov;222(8):3863.

12.
13.

Immunotoxins in cancer therapy: Review and update.

Akbari B, Farajnia S, Ahdi Khosroshahi S, Safari F, Yousefi M, Dariushnejad H, Rahbarnia L.

Int Rev Immunol. 2017 Jul 4;36(4):207-219. doi: 10.1080/08830185.2017.1284211. Epub 2017 Mar 1. Review.

PMID:
28282218
14.

Development of a Novel Human Single Chain Antibody Against EGFRVIII Antigen by Phage Display Technology.

Rahbarnia L, Farajnia S, Babaei H, Majidi J, Akbari B, Ahdi Khosroshahi S.

Adv Pharm Bull. 2016 Dec;6(4):563-571. doi: 10.15171/apb.2016.070. Epub 2016 Dec 22.

15.

Liposome-mediated RNA interference delivery against Erk1 and Erk2 does not equally promote chemosensitivity in human hepatocellular carcinoma cell line HepG2.

Mehdizadeh A, Somi MH, Darabi M, Farajnia S, Akbarzadeh A, Montazersaheb S, Yousefi M, Bonyadi M.

Artif Cells Nanomed Biotechnol. 2017 Dec;45(8):1612-1619. doi: 10.1080/21691401.2016.1269117. Epub 2017 Jan 6.

PMID:
28058860
16.

Isolation and characterization of a novel human scFv inhibiting EGFR vIII expressing cancers.

Rahbarnia L, Farajnia S, Babaei H, Majidi J, Dariushnejad H, Hosseini MK.

Immunol Lett. 2016 Dec;180:31-38. doi: 10.1016/j.imlet.2016.10.008. Epub 2016 Oct 29.

PMID:
27984065
17.

Rapid Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using Real-Time PCR.

Sahebi L, Ansarin K, Monfaredan A, Farajnia S, Nili S, Khalili M.

Jundishapur J Microbiol. 2016 Apr 16;9(10):e29147. eCollection 2016 Oct.

18.

Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A.

Akbari B, Farajnia S, Zarghami N, Mahdieh N, Rahmati M, Khosroshahi SA, Barzegar A, Rahbarnia L.

Anticancer Drugs. 2017 Mar;28(3):263-270. doi: 10.1097/CAD.0000000000000452.

PMID:
27861173
19.

Evolution of phage display technology: from discovery to application.

Rahbarnia L, Farajnia S, Babaei H, Majidi J, Veisi K, Ahmadzadeh V, Akbari B.

J Drug Target. 2017 Mar;25(3):216-224. doi: 10.1080/1061186X.2016.1258570. Epub 2016 Nov 21. Review.

PMID:
27819143
20.

Association of UCP2 -866G>A Polymorphism With Nonalcoholic Fatty Liver Disease in Patients From North-West of Iran.

Mohseni F, Farajnia S, Farhangi MA, Khoshbaten M, Jafarabadi MA.

Lab Med. 2017 Feb;48(1):65-72. doi: 10.1093/labmed/lmw052. Epub 2016 Oct 28.

PMID:
27794526
21.

Development of a Novel Human scFv Against EGFR L2 Domain by Phage Display Technology.

Rahbarnia L, Farajnia S, Babaei H, Majidi J, Veisi K, Khosroshahi SA, Tanomand A.

Curr Pharm Des. 2017;23(13):2009-2014. doi: 10.2174/1381612822666160928112208.

PMID:
27779085
22.

Photoperiod Modulates Fast Delayed Rectifier Potassium Currents in the Mammalian Circadian Clock.

Farajnia S, Meijer JH, Michel S.

ASN Neuro. 2016 Oct 3;8(5). pii: 1759091416670778. Print 2016 Oct.

23.

Nigella sativa oil with a calorie-restricted diet can improve biomarkers of systemic inflammation in obese women: A randomized double-blind, placebo-controlled clinical trial.

Mahdavi R, Namazi N, Alizadeh M, Farajnia S.

J Clin Lipidol. 2016 Sep-Oct;10(5):1203-11. doi: 10.1016/j.jacl.2015.11.019. Epub 2015 Dec 7.

PMID:
27678438
24.

Patterns of Drug Resistance Among Tuberculosis Patients in West and Northwestern Iran.

Sahebi L, Ansarin K, Mohajeri P, Khalili M, Monfaredan A, Farajnia S, Zadeh SK.

Open Respir Med J. 2016 Jun 30;10:29-35. doi: 10.2174/1874306401610010029. eCollection 2016.

25.

Invert biopanning: A novel method for efficient and rapid isolation of scFvs by phage display technology.

Rahbarnia L, Farajnia S, Babaei H, Majidi J, Veisi K, Tanomand A, Akbari B.

Biologicals. 2016 Nov;44(6):567-573. doi: 10.1016/j.biologicals.2016.07.002. Epub 2016 Aug 9.

PMID:
27520285
26.

Epidemiology and patterns of drug resistance among tuberculosis patients in Northwestern Iran.

Sahebi L, Ansarin K, Seyyedi M, Monfaredan A, Farajnia S, Moaddab SR, Rashedi J.

Indian J Med Microbiol. 2016 Jul-Sep;34(3):362-8. doi: 10.4103/0255-0857.188352.

27.

Comparative Evaluation of RUT, PCR and ELISA Tests for Detection of Infection with Cytotoxigenic H. pylori.

Jalalypour F, Farajnia S, Somi MH, Hojabri Z, Yousefzadeh R, Saeedi N.

Adv Pharm Bull. 2016 Jun;6(2):261-6. doi: 10.15171/apb.2016.036. Epub 2016 Jun 30.

28.

Major components of metabolic syndrome and nutritional intakes in different genotype of UCP2 -866G/A gene polymorphisms in patients with NAFLD.

Abbasalizad Farhangi M, Mohseni F, Farajnia S, Jafarabadi MA.

J Transl Med. 2016 Jun 14;14(1):177. doi: 10.1186/s12967-016-0936-3.

29.

Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR).

Akbari B, Farajnia S, Zarghami N, Mahdieh N, Rahmati M, Khosroshahi SA, Rahbarnia L.

Protein Expr Purif. 2016 Nov;127:8-15. doi: 10.1016/j.pep.2016.06.001. Epub 2016 Jun 11.

PMID:
27298212
30.

CD20-targeting in B-cell malignancies: novel prospects for antibodies and combination therapies.

Safdari Y, Ahmadzadeh V, Farajnia S.

Invest New Drugs. 2016 Aug;34(4):497-512. doi: 10.1007/s10637-016-0349-4. Epub 2016 Apr 13. Review.

PMID:
27075017
31.

Effect of Buspirone, Fluoxetine and 8-OH-DPAT on Striatal Expression of Bax, Caspase-3 and Bcl-2 Proteins in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rats.

Sharifi H, Mohajjel Nayebi A, Farajnia S, Haddadi R.

Adv Pharm Bull. 2015 Nov;5(4):491-5. doi: 10.15171/apb.2015.067. Epub 2015 Nov 30.

32.

Chaperone-Assisted Soluble Expression of a Humanized Anti-EGFR ScFv Antibody in E. Coli.

Veisi K, Farajnia S, Zarghami N, Khoram Khorshid HR, Samadi N, Ahdi Khosroshahi S, Zarei Jaliani H.

Adv Pharm Bull. 2015 Dec;5(Suppl 1):621-7. doi: 10.15171/apb.2015.084. Epub 2015 Dec 31.

33.

Development and evaluation of a single domain antibody against human epidermal growth factor receptor (EGFR).

Ahdi Khosroshahi S, Farajnia S, Ghiamirad M, Tanomand A, Veisi K, Rahbarnia L, Akbari B.

Protein Expr Purif. 2016 Apr;120:59-64. doi: 10.1016/j.pep.2015.12.005. Epub 2015 Dec 12.

PMID:
26690373
34.

New insights into the mechanisms of multidrug resistance in cancers.

Montazami N, Aghapour M, Farajnia S, Baradaran B.

Cell Mol Biol (Noisy-le-grand). 2015 Nov 25;61(7):70-80. Review.

PMID:
26612736
35.

Involvement of Glycogen Synthase Kinase-3β and Oxidation Status in the Loss of Cardioprotection by Postconditioning in Chronic Diabetic Male Rats.

Badalzadeh R, Mohammadi M, Yousefi B, Farajnia S, Najafi M, Mohammadi S.

Adv Pharm Bull. 2015 Sep;5(3):321-7. doi: 10.15171/apb.2015.045. Epub 2015 Sep 19.

36.

Molecular Epidemiology of Mycobacterium Tuberculosis Strains in the North-West and West of Iran.

Sahebi L, Ansarin K, Hoffner S, Farajnia S, Seyyedi M, Khalili M, Monfaredan A.

Ann Med Health Sci Res. 2015 Sep-Oct;5(5):334-9. doi: 10.4103/2141-9248.165249.

37.

The Central Role for Microenvironment in B-Cell Malignancies: Recent Insights into Synergistic Effects of its Therapeutic Targeting and Anti-CD20 Antibodies.

Ahmadzadeh V, Tofigh R, Farajnia S, Pouladi N.

Int Rev Immunol. 2016;35(2):136-55. doi: 10.3109/08830185.2015.1077830. Epub 2015 Sep 1. Review.

PMID:
26325124
38.

Oxidative Stress Responses to Nigella sativa Oil Concurrent with a Low-Calorie Diet in Obese Women: A Randomized, Double-Blind Controlled Clinical Trial.

Namazi N, Mahdavi R, Alizadeh M, Farajnia S.

Phytother Res. 2015 Nov;29(11):1722-8. doi: 10.1002/ptr.5417. Epub 2015 Jul 14.

PMID:
26179113
39.

Prevalence and risk factors of drug-resistant tuberculosis in border provinces of Iran.

Sahebi L, Ansarin K, Farajnia S, Monfaredan A, Sabour S.

Postgrad Med. 2015 Aug;127(6):600-6. doi: 10.1080/00325481.2015.1069168. Epub 2015 Jul 15.

PMID:
26174471
40.

Role of exon 7 PTEN Gene in Endometrial Carcinoma.

Kafshdooz L, Kafshdooz T, Tabrizi AD, Mohaddes Ardabili SM, Akbarzadeh A, Gharesouran J, Ghojazadeh M, Farajnia S.

Asian Pac J Cancer Prev. 2015;16(11):4521-4.

41.

Effects of Nigella sativa oil with a low-calorie diet on cardiometabolic risk factors in obese women: a randomized controlled clinical trial.

Mahdavi R, Namazi N, Alizadeh M, Farajnia S.

Food Funct. 2015 Jun;6(6):2041-8. doi: 10.1039/c5fo00316d.

PMID:
26029855
42.

Age-related changes in large-conductance calcium-activated potassium channels in mammalian circadian clock neurons.

Farajnia S, Meijer JH, Michel S.

Neurobiol Aging. 2015 Jun;36(6):2176-83. doi: 10.1016/j.neurobiolaging.2014.12.040. Epub 2015 Jan 31.

43.

Prevalence of Aminoglycoside Resistance Genes in Acinetobacter baumannii Isolates.

Aliakbarzade K, Farajnia S, Karimi Nik A, Zarei F, Tanomand A.

Jundishapur J Microbiol. 2014 Oct;7(10):e11924. doi: 10.5812/jjm.11924. Epub 2014 Oct 1.

44.

Natural inhibitors of PI3K/AKT signaling in breast cancer: emphasis on newly-discovered molecular mechanisms of action.

Safdari Y, Khalili M, Ebrahimzadeh MA, Yazdani Y, Farajnia S.

Pharmacol Res. 2015 Mar;93:1-10. doi: 10.1016/j.phrs.2014.12.004. Epub 2014 Dec 19. Review.

PMID:
25533812
45.

Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection.

Farajnia S, Peerayeh SN, Tanomand A, Majidi J, Goudarzi G, Naghili B, Rahbarnia L.

Can J Microbiol. 2015 Jan;61(1):60-4. doi: 10.1139/cjm-2014-0501.

PMID:
25496361
46.

Inhibition of mitochondrial permeability transition pore restores the cardioprotection by postconditioning in diabetic hearts.

Najafi M, Farajnia S, Mohammadi M, Badalzadeh R, Ahmadi Asl N, Baradaran B, Amani M.

J Diabetes Metab Disord. 2014 Nov 18;13(1):106. doi: 10.1186/s40200-014-0106-1. eCollection 2014.

47.

Development and Evaluation of a Cetuximab-based Humanized Single Chain Antibody Against EGFR-overexpressing Tumors.

Veisi K, Farajnia S, Zarghami N, Khorshid HR, Samadi N, Safdari Y, Ahmadzadeh V.

Drug Res (Stuttg). 2015 Dec;65(12):624-8. doi: 10.1055/s-0034-1394369. Epub 2014 Oct 21.

PMID:
25333654
48.

Antimicrobial Resistance Patterns and Prevalence of blaPER-1 and blaVEB-1 Genes Among ESBL-producing Pseudomonas aeruginosa Isolates in West of Iran.

Alikhani MY, Karimi Tabar Z, Mihani F, Kalantar E, Karami P, Sadeghi M, Ahdi Khosroshahi S, Farajnia S.

Jundishapur J Microbiol. 2014 Jan;7(1):e8888. doi: 10.5812/jjm.8888. Epub 2014 Jan 1.

49.

Design, expression and characterization of a single chain anti-CD20 antibody; a germline humanized antibody derived from Rituximab.

Ahmadzadeh V, Farajnia S, Hosseinpour Feizi MA, Khavarinejad RA.

Protein Expr Purif. 2014 Oct;102:45-51. doi: 10.1016/j.pep.2014.07.008. Epub 2014 Aug 1.

PMID:
25088934
50.

Development trends for generation of single-chain antibody fragments.

Farajnia S, Ahmadzadeh V, Tanomand A, Veisi K, Khosroshahi SA, Rahbarnia L.

Immunopharmacol Immunotoxicol. 2014 Oct;36(5):297-308. doi: 10.3109/08923973.2014.945126. Epub 2014 Aug 1. Review.

PMID:
25081575

Supplemental Content

Loading ...
Support Center